Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Ashot Papoyan
Advertisement
Ashot Papoyan is research scientist II at Tetragenetics Inc
Articles by Ashot Papoyan
Advertisement
Latest Updated Articles
An Alternative Platform for Rapid Production of Effective Subunit VaccinesPublished: October 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Everything to Know About Cell and Gene Therapy in 2025
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
